Skip to main content

Table 5 Median lipid profiles in the placebo and atorvastatin groups at day 4 of follow-up compared to baseline

From: Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)

 

Placebo

Difference from day 1 n= 31/31*

Atorvastatin

Difference from day 1 n= 23/25*

Comparison atorvastatin-placebo

P-value

Total cholesterol (mmol/L)

0.30

-0.50

-0.8 (-0.9, -0.8)

< 0.0001

LDL(mmol/L)

0.16

-0.63

-0.79 (-0.93, -0.47)

0.019

HDL (mmol/L)

-0.18

-0.40

-0.22 (-0.53, 0.01)

0.227

Triglycerides (mmol/L)

0.50

0.20

-0.30 (-1.0, 0.40)

0.79

  1. * Number of samples available for analysis. Denominator represents number of patients still in hospital at day 4. Values represent median and IQR. LDL, low density lipoprotein; HDL, high density lipoprotein.